J&J Beats $258M Risperdal Verdict In Split La. High Court
A split Louisiana Supreme Court on Tuesday nixed a $258 million jury award against Johnson & Johnson unit Janssen Pharmaceuticals Inc. over its marketing of the antipsychotic drug Risperdal, finding that...To view the full article, register now.
Already a subscriber? Click here to view full article